[HTML][HTML] Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential

H Kheraldine, O Rachid, AM Habib… - Advanced drug delivery …, 2021 - Elsevier
Drug delivery systems or vectors are usually needed to improve the bioavailability and
effectiveness of a drug through improving its pharmacokinetics/pharmacodynamics at an …

Poly (amidoamine)(PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy

J Li, H Liang, J Liu, Z Wang - International journal of pharmaceutics, 2018 - Elsevier
Abstract Poly (amidoamine)(PAMAM) dendrimers are well-defined, highly branched
macromolecules with numerous active amine groups on the surface. Because of their …

Cationic polymers and their therapeutic potential

SK Samal, M Dash, S Van Vlierberghe… - Chemical Society …, 2012 - pubs.rsc.org
The last decade has witnessed enormous research focused on cationic polymers. Cationic
polymers are the subject of intense research as non-viral gene delivery systems, due to their …

Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges

R Duncan, SCW Richardson - Molecular pharmaceutics, 2012 - ACS Publications
More than 40 nanomedicines are already in routine clinical use with a growing number
following in preclinical and clinical development. The therapeutic objectives are often …

Folic acid conjugated PAMAM-modified mesoporous silica-coated superparamagnetic iron oxide nanoparticles for potential cancer therapy

T Sagir, M Huysal, M Senel, S Isık, N Burgucu… - Journal of Colloid and …, 2022 - Elsevier
In this study, novel folate-receptor-targeted polyamidoamine (PAMAM) dendrimer functional
mesoporous silica-coated magnetic nanoparticles were prepared for drug delivery agents …

Poly (amidoamine) s: Past, present, and perspectives

P Ferruti - Journal of Polymer Science Part A: Polymer …, 2013 - Wiley Online Library
Poly (amidoamine) s (PAAs) are a family of synthetic polymers obtained by stepwise
polyaddition of prim‐or sec‐amines to bisacrylamides. Nearly all conceivable …

[HTML][HTML] Strategies in gene therapy for glioblastoma

A Kwiatkowska, MS Nandhu, P Behera, EA Chiocca… - Cancers, 2013 - mdpi.com
Glioblastoma (GBM) is the most aggressive form of brain cancer, with a dismal prognosis
and extremely low percentage of survivors. Novel therapies are in dire need to improve the …

Dendrimer-mediated approaches for the treatment of brain tumor

N Dwivedi, J Shah, V Mishra… - Journal of …, 2016 - Taylor & Francis
Worldwide, the cancer appeared as one of the most leading cause of morbidity and
mortality. Among the various cancer types, brain tumors are most life threatening with low …

[HTML][HTML] MicroRNAs as molecular targets for cancer therapy: on the modulation of microRNA expression

PM Costa, MC Pedroso de Lima - Pharmaceuticals, 2013 - mdpi.com
The discovery of small RNA molecules with the capacity to regulate messenger RNA
(mRNA) stability and translation (and consequently protein synthesis) has revealed an …

Use of poly (amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium

P Urbán, JJ Valle-Delgado, N Mauro, J Marques… - Journal of Controlled …, 2014 - Elsevier
Current malaria therapeutics demands strategies able to selectively deliver drugs to
Plasmodium-infected red blood cells (pRBCs) in order to limit the appearance of parasite …